Consistently, Treg depletion in an experimental model of NASH-related HCC significantly limits tumour burden by increasing the hepatic abundance of INF-γ-producing CD4+ and CD8+ T-cells [40]. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatohepatitis.